Bio-Med Health Care Products Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.63 Cr
as on 16-11-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 101.07 Cr
as on 16-11-2024
- Satisfied Charges ₹ 73.41 Cr
as on 16-11-2024
- Revenue 3.78%
(FY 2023)
- Profit 23.64%
(FY 2023)
- Ebitda 55.23%
(FY 2023)
- Net Worth 5.42%
(FY 2023)
- Total Assets -2.51%
(FY 2023)
About Bio-Med Health Care Products
The Corporate was formerly known as Bio-Med Health Care Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.63 Cr.
The company currently has active open charges totaling ₹101.07 Cr. The company has closed loans amounting to ₹73.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepak Arora, Nirmal Arora, and Jagdish Arora serve as directors at the Company.
- CIN/LLPIN
U33112HR2002PTC034806
- Company No.
034806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bio-Med Health Care Products Private Limited offer?
Bio-Med Health Care Products Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Oxygen Mask, Infusion Syringes & Supplies, Medical Tubes, Oxygen Mask, Flowmeter & Humidifier Bottle, Bandages, Cannula Fixators, Packaging Caps & Seals, Bottle Stoppers, Syringes.
Who are the key members and board of directors at Bio-Med Health Care Products?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Deepak Arora | Director | 09-Jan-2002 | Current |
Nirmal Arora | Director | 01-Jun-2002 | Current |
Jagdish Arora | Director | 09-Jan-2002 | Current |
Financial Performance of Bio-Med Health Care Products.
Bio-Med Health Care Products Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.78% increase. The company also saw a substantial improvement in profitability, with a 23.64% increase in profit. The company's net worth moved up by a moderate rise of 5.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Med Health Care Products?
In 2022, Bio-Med Health Care Products had a promoter holding of 89.11% and a public holding of 10.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 11 Apr 2023 | ₹6.73 M | Open |
Hdfc Bank Limited Creation Date: 29 Mar 2023 | ₹2.51 M | Open |
Sidbi Creation Date: 22 Mar 2023 | ₹5.40 M | Open |
How Many Employees Work at Bio-Med Health Care Products?
Unlock and access historical data on people associated with Bio-Med Health Care Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Med Health Care Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Med Health Care Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.